SIEN - Sientra, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
22.27
-0.76 (-3.30%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close23.03
Open23.11
Bid21.80 x 900
Ask26.28 x 800
Day's Range21.85 - 23.32
52 Week Range8.79 - 26.79
Volume281,297
Avg. Volume315,713
Market Cap633.085M
Beta (3Y Monthly)-2.60
PE Ratio (TTM)N/A
EPS (TTM)-3.35
Earnings DateMay 4, 2017 - May 8, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.00
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    Investor Expectations to Drive Momentum within Cincinnati Bell, Hooker Furniture, AgroFresh Solutions, Forward Industries, Abeona Therapeutics, and Sientra — Discovering Underlying Factors of Influence

    NEW YORK, Oct. 16, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Are Options Traders Betting on a Big Move in Sientra (SIEN) Stock?
    Zacks8 days ago

    Are Options Traders Betting on a Big Move in Sientra (SIEN) Stock?

    Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

  • SEC sues U.S. breast-implant company's ex-CEO after stock dive
    Reuterslast month

    SEC sues U.S. breast-implant company's ex-CEO after stock dive

    Hani Zeini, 54, was accused of letting the offering close on Sept. 23, 2015, despite having learned three days earlier from the chief executive of the company's sole supplier that European implant sales would be suspended because contamination had been detected in an audit of manufacturing procedures. Sientra's share price sank 52.9 percent on Sept. 24, 2015, to $9.70 from $20.58, after it disclosed that the U.K. Medicines and Healthcare Products Regulatory Agency had suspended the certificate needed for the supplier, Brazil's Silimed, to sell the implants. The SEC said Zeini had hid "damaging" details from "every other professional" working on his Santa Barbara, California-based company's 3 million share offering, including its chief financial officer, directors, lawyers, auditors and bankers, and tried to cover his tracks after it was done.

  • Reuterslast month

    SEC sues ex-CEO of California breast implant company after stock nosedived

    The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering. Hani Zeini was accused of letting the offering close on Sept. 23, 2015, despite having learned three days earlier from the chief executive of the company's sole supplier that European implant sales would be suspended because contamination had been detected in an audit of manufacturing procedures. Sientra's share price sank 52.9 percent on Sept. 24, 2015, to $9.70 from $20.58, after it disclosed that the U.K. Medicines and Healthcare Products Regulatory Agency had suspended the certificate needed for the supplier, Brazil's Silimed, to sell the implants.

  • GlobeNewswire2 months ago

    Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results

    NEW YORK, Aug. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amtech ...

  • PR Newswire2 months ago

    Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations

    SANTA BARBARA, Calif., Aug. 15, 2018 /PRNewswire/ -- Sientra, Inc. (SIEN), a medical aesthetics company, today announced that its FULL CIRCLE grant applications are now open for any U.S. based, nonprofit breast cancer organizations supporting breast cancer aid, research, patient outreach, advocacy, and prevention. The application period will end on September 15, 2018, and recipients will be announced by Sientra in October 2018. Sientra FULL CIRCLE™ is a first-of its-kind charitable program aimed at aiding nonprofits in the breast cancer community who are committed to making a meaningful difference.

  • GlobeNewswire2 months ago

    Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    SANTA BARBARA, Calif., Aug. 10, 2018-- Sientra, Inc. today announced that on August 8, 2018, Paul Little received an equity award grant from the Compensation Committee of the Board of Directors approved ...

  • Associated Press2 months ago

    Sientra: 2Q Earnings Snapshot

    The Santa Barbara, California-based company said it had a loss of 73 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

  • GlobeNewswire2 months ago

    Sientra Reports Second Quarter 2018 Financial Results

    Achieves Record Net Sales of $17.6 Million. Appoints Patrick F. Williams to General Manager of miraDry Business Segment. Appoints Aesthetics Veteran Paul Little as Chief Financial Officer.

  • ACCESSWIRE2 months ago

    Sientra, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / Sientra, Inc. (NASDAQ: SIEN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern Time. To listen ...

  • PR Newswire3 months ago

    Sientra to Launch State-of-the-Art Innovation Facility

    SANTA BARBARA, Calif., July 31, 2018 /PRNewswire/ -- Sientra, Inc. (SIEN), a medical aesthetics company, today announced its investment in opening a new state-of-the-art Sientra Lab and Innovation Center of Excellence (SLICE) near its corporate headquarters in Santa Barbara, CA. The new development lab facility will enable Sientra to accelerate its efforts on key portfolio additions and enhancements.

  • GlobeNewswire3 months ago

    Sientra to Present at the Canaccord 38th Annual Growth Stock Conference

    SANTA BARBARA, Calif., July 25, 2018-- Sientra, Inc., a medical aesthetics company, announced today that members of the management team are scheduled to present at the Canaccord 38 th Annual Growth Conference.. ...

  • GlobeNewswire3 months ago

    Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018

    SANTA BARBARA, Calif., July 24, 2018-- Sientra, Inc., a medical aesthetics company, announced today that the Company will release its second quarter 2018 financial results on Tuesday, August 7, 2018 after ...

  • Implied Volatility Surging for Sientra (SIEN) Stock Options
    Zacks4 months ago

    Implied Volatility Surging for Sientra (SIEN) Stock Options

    Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

  • ACCESSWIRE4 months ago

    Complimentary Technical Snapshots on Merit Medical Systems and Three More Medical Supplies Stocks

    Ahead of today's trading session, WallStEquities.com features the Medical Instruments and Supplies manufacturing industry, which primarily researches, develops, and produces nonelectronic medical, surgical, dental, and veterinary instruments and apparatus, such as syringes, anesthesia apparatus, and blood transfusion equipment.Under evaluation this morning are these four stocks: Mazor Robotics Ltd (NASDAQ: MZOR), Merit Medical Systems Inc. (NASDAQ: MMSI), Nxstage Medical Inc. (NASDAQ: NXTM), and Sientra Inc. (NASDAQ: SIEN). All you have to do is sign up today for this free limited time offer by clicking the link below.

  • ACCESSWIRE5 months ago

    Free Daily Technical Summary Reports on Valeritas and Three Other Medical Supplies Stocks

    Stock Research Monitor: ILMN, NXTM, and SIEN LONDON, UK / ACCESSWIRE / May 22, 2018 / If you want a free Stock Review on VLRX sign up now at www.wallstequities.com/registration . For today, WallStEquities.com ...

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of SIEN earnings conference call or presentation 9-May-18 8:30pm GMT

    Q1 2018 Sientra Inc Earnings Call

  • Associated Press5 months ago

    Sientra: 1Q Earnings Snapshot

    On a per-share basis, the Santa Barbara, California-based company said it had a loss of 99 cents. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...